Are you Dr. Jessop?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 29 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161- Is this information wrong?
Summary
- Dr. Aaron Jessop, MD is a board certified nuclear medicine physician in Houston, Texas. He is currently licensed to practice medicine in Texas and Tennessee. He is affiliated with Vanderbilt University Medical Center.
Education & Training
- University of Nebraska College of MedicineClass of 2006
Certifications & Licensure
- TN State Medical License 2008 - 2024
- TX State Medical License 2010 - 2024
- American Board of Nuclear Medicine Nuclear Medicine
Publications & Presentations
PubMed
- A Pilot Nonrandomized Controlled Trial Examining the Use of Artificial Tears on the Radioactivity of Tears After Radioactive Iodine Treatment for Thyroid Cancer.Jared V Grice, Xiangyu Ji, Qingxia Chen, Behin Barahimi, Francois Codere, Lee, I., Mawn, L., Bischoff, L., Jessop, A., Sobel, R.> ;Thyroid. 2024 Jan 1
- 3 citationsFactors Associated With Radioactive Iodine Therapy-Acquired Nasolacrimal Duct Obstruction.Irene T Lee, Wencong Chen, Qingxia Chen, Heather A Cole, Lindsay A Bischoff, Aaron C Jessop, Rachel K Sobel> ;Endocrine Practice. 2022 Dec 1
- 5 citationsExternal Validation of a Clinical Score for Patients With Neuroendocrine Tumors Under Consideration for Peptide Receptor Radionuclide Therapy.Satya Das, Aman Chauhan, Liping Du, Katharine E Thomas, Aasems Jacob, Aimee Schad, Shikha Jain, Aaron Jessop, Chirayu Shah, David Eisner, Dana B Cardin, Kristen K Ciom...> ;JAMA Network Open. 2022 Jan 4
- Join now to see all
Press Mentions
- Clinical Score Can Guide PRRT Therapy Decisions for Neuroendocrine TumorsJanuary 19th, 2022
Hospital Affiliations
- Vanderbilt University Medical CenterNashville, Tennessee